C M Bidwell & Associates LTD Atri Cure, Inc. Transaction History
C M Bidwell & Associates LTD
- $189 Million
- Q2 2025
A detailed history of C M Bidwell & Associates LTD transactions in Atri Cure, Inc. stock. As of the latest transaction made, C M Bidwell & Associates LTD holds 116 shares of ATRC stock, worth $4,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116
Previous 116
-0.0%
Holding current value
$4,319
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
220Shares Held
51.8MCall Options Held
33.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA4.91MShares$183 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$172 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA3.97MShares$148 Million0.02% of portfolio
-
Alliancebernstein L.P. New York, NY3.57MShares$133 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3.06MShares$114 Million1.62% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.73B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...